3D Systems Corporation (DDD) Retires $88 Million in Debt; Its 3D bioprinted, bioabsorabable Nerve Repair Device Receives FDA Approval

3D Systems Corporation (NYSE:DDD) is included in our list of the 10 Best AI Stocks to Buy Under $3.

3D Systems Corporation (DDD) Retires $88 Million in Debt; Its 3D bioprinted, bioabsorabable Nerve Repair Device Receives FDA Approval

On June 24, 2025, 3D Systems Corporation (NYSE:DDD) successfully restructured its debt, retiring $88 million in debt, issuing new notes maturing in 2030, and repurchasing 8 million shares to reduce dilution. With this move, the company aims to enhance its financial flexibility.

Meanwhile, on June 26, 2025, 3D Systems Corporation (NYSE:DDD) achieved a critical medical breakthrough. Its 3D bioprinted, bioabsorbable nerve repair device, developed in partnership with TISSIUM, received FDA approval. This regulatory approval strengthens the company’s leadership in regenerative medicine, following years of innovation in printing living tissues.

Therefore, 3D Systems Corporation (NYSE:DDD) is well-positioned to redefine the possibilities of additive manufacturing with its strong balance sheet and ongoing progress in healthcare.

With the help of its AI-driven software, 3D Systems Corporation (NYSE:DDD) delivers precision additive manufacturing solutions, serving aerospace, healthcare, materials, and bioprinting segments. It is included in our list of the best AI stocks.

While we acknowledge the potential of DDD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than DDD and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 12 Cheap Value Stocks to Buy Now According to Warren Buffett and 7 Best Potash Stocks to Buy According to Analysts.

Disclosure: None.